Man

Jeffri Stevens Retamal Santibañez

Profesor asistente

Universidad de Santiago de Chile

Santiago, Chile

Líneas de Investigación


Bioquímico, doctor en Ciencias Farmacéuticas y Farmacología, con énfasis en señalización de biología celular/farmacólogo. Científico experimentado, experto en señalización del dolor y farmacología de receptores acoplados a proteína G (GPCR), con más

Educación

  •  Farmacologia y ciencias farmaceuticas, MONASH UNIVERSITY. Australia, 2021
  •  Bioquimica, UNIVERSIDAD ANDRES BELLO. Chile, 2013
  •  Bioquimico, UNIVERSITE DE MONS-HAINAUT. Chile, 2010

Experiencia Académica

  •   Asistente de investigación Full Time

    UNIVERSIDAD DE SANTIAGO DE CHILE

    Quimica y biologia

    Chile

    2013 - A la fecha

  •   research assistant Full Time

    MONASH UNIVERSITY

    Pharmaceutical science

    Melbourne, Australia

    2016 - A la fecha

  •   Postdoctoral Full Time

    MONASH UNIVERSITY

    Pharmacy and Pharmaceutical science

    Melbourne, Australia

    2020 - 2021

  •   Research associate Full Time

    NEW YORK UNIVERSITY

    Dentistry

    New York, Estados Unidos

    2021 - 2023

Premios y Distinciones

  •   Best publication

    MONASH UNIVERSITY

    Australia, 2020

    Best publication in the faculty, 2020 Ph-responsive nanoparticles, Published in nature nanotechnology

  •   Beca Chile para doctorado en el extrajero

    MONASH UNIVERSITY

    Chile, 2017

    Beca chile para doctorado en el extrajero


 

Article (12)

Acaricidal activity of geraniol-loaded lignin nanoparticles for the control of Brevipalpus chilensis: an eco-friendly approach to crop protection
N-methyl-D-aspartate receptor activation is downstream coupled to pannexin 1 opening by Src kinase in dorsal horn neurons: an essential link for mechanical hyperalgesia in nerve-injured rats
Mice expressing fluorescent PAR<sub>2</sub> reveal that endocytosis mediates colonic inflammation and pain
NMDA and P2X7 Receptors Require Pannexin 1 Activation to Initiate and Maintain Nociceptive Signaling in the Spinal Cord of Neuropathic Rats
Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain
A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes
Serotonin-induced vascular permeability is mediated by transient receptor potential vanilloid 4 in the airways and upper gastrointestinal tract of mice
The transient receptor potential vanilloid 4 (TRPV4) ion channel mediates protease activated receptor 1 (PAR1)-induced vascular hyperpermeability
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain
Burst-Like Subcutaneous Electrical Stimulation Induces BDNF-Mediated, Cyclotraxin B-Sensitive Central Sensitization in Rat Spinal Cord
Pannexin 1: A novel participant in neuropathic pain signaling in the rat spinal cord

Review (1)

Internalized GPCRs as Potential Therapeutic Targets for the Management of Pain
1
HÉCTOR BURGOS

INVESTIGADOR

FACULTAD DE CIENCIAS

UNIVERSIDAD SANTO TOMÁS, Chile

SANTIAGO, Chile

4
Luis Constandil

Profesor Titular

Biología

Universidad de Santiago de Chile

Santiago, Chile

1
NATALIA JUICA

Bioquímico

Facultad de Ciencias de la Salud

Universidad SEK

Santiago, Chile

2
David Bravo

CEO

Research and Innovation

Pannex Therapeutics

Santiago, Chile

13
Jeffri Retamal

Profesor asistente

Biologia

Universidad de Santiago de Chile

Santiago, Chile